Long-Term Improvements in Health-Related Quality of Life of Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s20, 2021. DOI: 10.25251/skin.5.supp.20. Disponível em: https://skin.dermsquared.com/skin/article/view/1173. Acesso em: 8 jun. 2025.